Elisabetta Ferretti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	CURRENT ONCOLOGY REPORTS	2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?	PHARMACOLOGY & THERAPEUTICS	2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling	NPJ PRECISION ONCOLOGY	2024
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Open-ST: High-resolution spatial transcriptomics in 3D	CELL	2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature	CANCERS	2024
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation	CELL DEATH DISCOVERY	2024
Building an in vitro model of sarcopenic obesity	INTERNATIONAL JOURNAL OF BONE FRAGILITY	2024
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food	NUTRIENTS	2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue Recovery	CELLS	2023
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy	CANCERS	2023
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2023
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo	BIOLOGY DIRECT	2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer	EUROPEAN UROLOGY ONCOLOGY	2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance	BIOMÉDECINE & PHARMACOTHÉRAPIE	2023
Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) - Proceedings from the SOGLI consortium meeting in rome November 2022	CLINICAL NUTRITION	2023
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors	JOURNAL OF TRANSLATIONAL MEDICINE	2023
β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY	2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs	JOURNAL OF TRANSLATIONAL MEDICINE	2023

Progetti di Ricerca

Defining the biological role of endocrine disruptors (ED) in breast cancer development and progression
Protein Kinase Inhibitor treatment in Advanced Thyroid Cancer: evaluation of liquid biopsy as a tool for prediction of response to therapy

Gruppi di ricerca

Integrated Diagnostics in Prostate Cancer supported by Computational Algorithms (AI and network analysis)

Gestational diabetes; Risk Factors; Outcomes

Laboratori di ricerca

Functional omics data and Precision Medicine